AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
DEVELOPMENT OF SINGLE-AGENT CHEMOTHERAPY REGIMENS FOR GESTATIONAL TROPHOBLASTIC DISEASE
Authors: HOMESLEY HD
Citation: Hd. Homesley, DEVELOPMENT OF SINGLE-AGENT CHEMOTHERAPY REGIMENS FOR GESTATIONAL TROPHOBLASTIC DISEASE, Journal of reproductive medicine, 39(3), 1994, pp. 185-192
LYMPH-NODE FINDINGS AND OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE VULVA
Authors: HOMESLEY HD
Citation: Hd. Homesley, LYMPH-NODE FINDINGS AND OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE VULVA, Cancer, 74(9), 1994, pp. 2399-2402
LYMPH-NODE FINDINGS AND OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE VULVA
Authors: HOMESLEY HD
Citation: Hd. Homesley, LYMPH-NODE FINDINGS AND OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE VULVA, Cancer, 74(9), 1994, pp. 2399-2402
PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN REFRACTORY ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: SUTTON GP BLESSING JA HOMESLEY HD MCGUIRE WP ADCOCK L
Citation: Gp. Sutton et al., PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN REFRACTORY ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Cancer, 73(5), 1994, pp. 1453-1455
THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA
Authors: HOSKINS WJ MCGUIRE WP BRADY MF HOMESLEY HD CREASMAN WT BERMAN M BALL H BEREK JS
Citation: Wj. Hoskins et al., THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA, American journal of obstetrics and gynecology, 170(4), 1994, pp. 974-980
CIRCADIAN-TIMED COMBINATION DOXORUBICIN-CISPLATIN CHEMOTHERAPY FOR ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
Authors: BARRETT RJ BLESSING JA HOMESLEY HD TWIGGS L WEBSTER KD
Citation: Rj. Barrett et al., CIRCADIAN-TIMED COMBINATION DOXORUBICIN-CISPLATIN CHEMOTHERAPY FOR ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP, American journal of clinical oncology, 16(6), 1993, pp. 494-496
A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER
Authors: ASBURY RF BLESSING JA LOOK KY CLARKEPEARSON D HOMESLEY HD
Citation: Rf. Asbury et al., A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 16(6), 1993, pp. 529-531
STEROID-RECEPTOR CONCENTRATIONS IN ENDOMETRIAL CARCINOMA - EFFECT ON SURVIVAL IN SURGICALLY STAGED PATIENTS
Authors: KADAR N MALFETANO JH HOMESLEY HD
Citation: N. Kadar et al., STEROID-RECEPTOR CONCENTRATIONS IN ENDOMETRIAL CARCINOMA - EFFECT ON SURVIVAL IN SURGICALLY STAGED PATIENTS, Gynecologic oncology, 50(3), 1993, pp. 281-286
PROGNOSTIC FACTORS FOR GROIN NODE METASTASIS IN SQUAMOUS-CELL CARCINOMA OF THE VULVA (A GYNECOLOGIC-ONCOLOGY-GROUP-STUDY)
Authors: HOMESLEY HD BUNDY BN SEDLIS A YORDAN E BEREK JS JAHSHAN A MORTEL R
Citation: Hd. Homesley et al., PROGNOSTIC FACTORS FOR GROIN NODE METASTASIS IN SQUAMOUS-CELL CARCINOMA OF THE VULVA (A GYNECOLOGIC-ONCOLOGY-GROUP-STUDY), Gynecologic oncology, 49(3), 1993, pp. 279-283
TOPICAL SUCRALFATE IN THE TREATMENT OF VAGINAL ULCERATION
Authors: LENTZ SS BARRETT RJ HOMESLEY HD
Citation: Ss. Lentz et al., TOPICAL SUCRALFATE IN THE TREATMENT OF VAGINAL ULCERATION, Obstetrics and gynecology, 81(5), 1993, pp. 869-871
RANDOMIZED COMPARISON OF CISPLATIN PLUS EPIRUBICIN OR DOXORUBICIN FORADVANCED EPITHELIAL OVARIAN-CARCINOMA - A MULTICENTER TRIAL
Authors: HOMESLEY HD HARRY DS OTOOLE RV HOOGSTRATEN B FRANKLIN EW CAVANAGH D NAHHAS WA SMITH JJ LOVELACE JV
Citation: Hd. Homesley et al., RANDOMIZED COMPARISON OF CISPLATIN PLUS EPIRUBICIN OR DOXORUBICIN FORADVANCED EPITHELIAL OVARIAN-CARCINOMA - A MULTICENTER TRIAL, American journal of clinical oncology, 15(2), 1992, pp. 129-134
Risultati: 1-25 | 26-36 |